Circulating free fatty acids are a reflect of the balance between lipogenesis and lipolysis that takes place mainly in adipose tissue. We have found that mice deficient for RGS4 have increased circulating catecholamines, and increased free fatty acids (FFA). Consequently, RGS4-/-mice have increased concentration of circulating free fatty acids, abnormally accumulate fatty acids in liver, resulting in liver steatosis, and show a higher degree of glucose intolerance, and decreased insulin secretion in pancreas.
catecholamines, which are major signaling hormones (2) . Catecholamines are the primary activators of fasting-induced lipolysis (1, 3) , although postprandial plasma catecholamine concentration may be higher than in the fasting state, indicating increased sympathetic nervous system activity after meals (reviewed in (4)).
Upon binding to β-adrenergic receptors, catecholamines increase intracellular cAMP concentration, resulting in the activation of PKA, which phosphorylates and activates HSL.
Phosphorylation of HSL results in increased hydrolytic activity, and consequently leads to enhanced TG hydrolysis (1) . Other lipases, such as ATGL are also the final effectors of lipolytic signaling in adipocytes (5 
Materials and methods

Animals
Generation of RGS4 -/-mouse line has been previousely described (9) . Only male mice were and infection of 3T3-L1 cells was performed as described previously (13) . Infection efficiency was estimated at 90%. Pooled clones were differentiated as described.
Protein expression assays
For protein extraction tissues were homogenized 
Statistical analysis
Data are presented as means ± standard error of the mean (S.E.M). Group means were compared by factorial analysis of variance (ANOVA).
Differences were considered statistically significant at p < 0.05.
Results
Increased fasting FFA in RGS4-/-mice and β-
agonist-induced lipolysis in adipose tissue of
RGS4-/-mice
Previous studies showed decreased body weight in RGS4-/-compared to RGS4+/+ mice, suggesting the implication of RGS4 in adipose tissue biology (9) . We therefore first analyzed whole body and relative WAT weights in these mice. No significant differences were observed either in body or in WAT weights ( Fig. 1A-B ).
In contrast, we found consistent and significantly increased circulating fasting FFA in RGS4-/-compared to RGS4+/+ mice, independent of body or WAT weights (Fig. 1C ).
Since no differences in food intake (data not shown), or in WAT weight (Fig. 1B) This suggested that RGS4 is implicated in the response of WAT to lipolytic stimulation. Next, the anti-lipolytic effects of insulin were tested.
Insulin administration to fasted RGS4+/+ mice resulted, as expected in a 2.5-fold decrease in circulating FFA (Fig. 1E ). An almost identical decrease in circulating FFA levels was observed when RGS4-/-mice were insulin-stimulated ( Fig. 1E) . These results indicated that the antilipolytic mechanisms are not impaired in RGS4-/-mice. Furthermore, increased lipolysis in WAT of RGS4-/-mice was further demonstrated by increased phosphorylation of the rate-limiting lipolytic enzyme, the hormone-sensitive lipase (HSL; Fig. 1F ).
Abnormal fatty liver, hyperinsulinemia, and hyperglycemia in RGS4-/-mice
Increased fasting FFA is a risk factor for fatty liver and insulin resistance. A first interesting observation was the pale appearance of liver from RGS4-/-mice, suggesting increased fat accumulation ( Fig. 2A) . This was further demonstrated by Oil Red O staining ( Fig. 2A) and triglyceride quantification analysis, which showed increased triglyceride content in liver from RGS4-/-, compared to RGS4+/+ mice (Fig.   2B ). These differences were further increased when TG content of the livers of high fat diet (HFD)-fed RGS4-/-and +/+ mice were analyzed ( Fig. 2B ). Lipid accumulation in muscles of RGS4-/-compared to RGS4+/+ mice was also observed in normal fed mice (Fig.2C ), suggesting a more general effects. Moreover, gene expression analysis showed increased mRNA expression of markers of fatty acid content and synthesis, such as aP2, Gpd1, or PEPCK, in livers of RGS4-/-compared to RGS4+/+ mice (Fig. 2D) . The increased lipid content in liver was correlated with increased glucose and insulin levels in serum of fasted RGS4-/-mice ( Fig. 2E-F) , which was overall consistent with the observed increase in circulating FFA in RGS4-/-mice.
Impaired glucose homeostasis and insulin secretion in RGS4-/-mice
Liver steatosis, hyperglycemia, and hyperinsulinemia are strong predictors of insulin resistance. We therefore evaluated glucose homeostasis in RGS4-/-and +/+ mice.
Intraperitoneal glucose tolerance test (IPGTT)
showed a significant trend of RGS4-/-mice towards glucose intolerance, compared to RGS4+/+ mice (Fig. 3A) . These differences were even more pronounced when IPGTT was performed on high fat diet fed mice (Fig. 3B ).
Glucose intolerance in RGS4-/-mice was correlated with a decrease in insulin secretion in response to a glucose load (Fig. 3C) . These results strongly suggested that RGS4 is implicated in the control of glucose homeostasis. 3D ), suggesting that the decrease in insulin secretion in response to glucose observed in RGS4-/-mice ( Fig. 3C) was rather secondary to the toxic effects of FFA.
No effects of RGS4 in adipocyte differentiation
and lipid content.
To elucidate the implication of RGS4 in WAT development or function we first analyzed RGS4 mRNA expression during the adipocyte differentiation program of 3T3-L1
preadipocytes. RGS4 was expressed in 3T3-L1 preadipocytes, whereas its expression declined during the differentiation process reaching the limits of detection in fully differentiated adipocytes ( Fig. 2A ). In addition, no differences in the differentiation capacity was observed, as assessed by oil-red-O staining between 3T3-L1 cells infected with retrovirus expressing either RGS4 or empty vectors (Fig. 2B) . Furthermore, the lack of differences in lipid content suggested a normal balance between lipolysis and lipogenesis in RGS4-overexpressing cells. RGS4 overexpression in these 3T3-L1 cells was verified by qPCR ( Fig. 2C ). Taken together these results suggested that the observed effects of RGS4 on lipolysis (Fig. 1) were not cell autonomous of WAT. Furthermore, basal catecholamine secretion levels were increased in adrenals from RGS4-/compared to +/+ mice ( Fig. 4D-E) . Altogether, these results suggest that RGS4 negatively regulates catecholamine secretion in adrenal glands.
Discussion
Circulating catecholamines are mainly secreted by adrenal glands in response to synapticallyreleased ACh at the splanchnic nerve terminals synapsing onto chromaffin cells. ACh exerts its effects through activation of post-synaptic nicotinic and muscarinic cholinergic receptors (16, 17) . RGS4 has been shown to participate in the attenuation of calcium signaling in CHO and acinar pancreatic cells (18) (19) (20) . Enough evidence has led to propose RGS4 as a modulator of Ca 2+ oscillations elicited by many hormones and neurotransmitters, such as ACh (reviewed in (Fig. 3) .
In summary, we have shown that RGS4, which has been so far described as a regulator of neurological processes is also implicated in the control of adipose tissue lipolysis through the regulation of catecholamine secretion. As a result, RGS4-/-mice have increased circulating FFA, liver steatosis, and glucose intolerance. 
